Rigel Pharmaceuticals Inc (RIGL)
EBITDA Margin
32.03%
Quarterly · Period ending:
RIGL EBITDA Margin
Latest reported32.03%period ending
Latest reported32.03%period ending
RIGL Quarterly EBITDA Margin (100.00% → 32.03%)
Quarterly ebitda margin
High-resolution chart · PNG
RIGL ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -195.6452% | |
| -88.8541% | |
| -1,106.324% | |
| 100% | |
| 100% | |
| 100% |